Cytotoxic effect of 2,6-bis(4-hydroxy-3-methoxybenzylidene) cyclohexanone (BHMC) and curcumin on human liver cancer cells, HepG2

Introduction: Curcumin is an active constituent derived from turmeric with a variety of pharmacological activities. It suppressed cell proliferation and induced apoptosis in several cancer cell lines. However, due to its poor bio-availability, derivative analogue of curcumin has been synthesized to...

Full description

Bibliographic Details
Main Authors: Syed Alwi, Sharifah Sakinah, Zahari, Syazwan, Haron, Aminah Suhaila, Alexander, Henna Roshini
Format: Article
Language:English
Published: Faculty of Medicine and Health Sciences, Universiti Putra Malaysia 2019
Online Access:http://psasir.upm.edu.my/id/eprint/70040/
http://psasir.upm.edu.my/id/eprint/70040/1/2019070210005107_MJMHS_SP2_2019.pdf
_version_ 1848856577218445312
author Syed Alwi, Sharifah Sakinah
Zahari, Syazwan
Haron, Aminah Suhaila
Alexander, Henna Roshini
author_facet Syed Alwi, Sharifah Sakinah
Zahari, Syazwan
Haron, Aminah Suhaila
Alexander, Henna Roshini
author_sort Syed Alwi, Sharifah Sakinah
building UPM Institutional Repository
collection Online Access
description Introduction: Curcumin is an active constituent derived from turmeric with a variety of pharmacological activities. It suppressed cell proliferation and induced apoptosis in several cancer cell lines. However, due to its poor bio-availability, derivative analogue of curcumin has been synthesized to enhance the drug-like effects. BHMC was synthesized by removing β-diketone moiety from curcumin structure and modify it into conjugated double bonds. It has been proved to exhibit stronger anticancer effects with improved bioavailability compared to curcumin. Objective: This study aims to investigate the toxicity effect of BHMC and curcumin on human liver cancer, HepG2 and non-cancer mouse fibroblast, 3T3. Methods: Both cell lines were purchased from ATCC and cultured in supplemented DMEM. Cell viability was determined via MTT assay and confirmed with trypan blue assay. Morphology hallmarks of apoptosis of both treated cells were analyzed using inverted microscope at 40X magnifications. Results: BHMC and curcumin were very potent towards HepG2 and normal 3T3. These data were further confirmed with trypan blue assay which showed that both compounds significantly reduced the percentage of HepG2 and 3T3 cells viability. Both treated cells also displayed all the morphology hallmarks of apoptosis upon treatment. Conclusion: BHMC has a greater cytotoxicity effect on HepG2 compared to curcumin despite its non-selective cytotoxicity effect on non-cancer 3T3.
first_indexed 2025-11-15T11:43:52Z
format Article
id upm-70040
institution Universiti Putra Malaysia
institution_category Local University
language English
last_indexed 2025-11-15T11:43:52Z
publishDate 2019
publisher Faculty of Medicine and Health Sciences, Universiti Putra Malaysia
recordtype eprints
repository_type Digital Repository
spelling upm-700402019-08-16T00:38:51Z http://psasir.upm.edu.my/id/eprint/70040/ Cytotoxic effect of 2,6-bis(4-hydroxy-3-methoxybenzylidene) cyclohexanone (BHMC) and curcumin on human liver cancer cells, HepG2 Syed Alwi, Sharifah Sakinah Zahari, Syazwan Haron, Aminah Suhaila Alexander, Henna Roshini Introduction: Curcumin is an active constituent derived from turmeric with a variety of pharmacological activities. It suppressed cell proliferation and induced apoptosis in several cancer cell lines. However, due to its poor bio-availability, derivative analogue of curcumin has been synthesized to enhance the drug-like effects. BHMC was synthesized by removing β-diketone moiety from curcumin structure and modify it into conjugated double bonds. It has been proved to exhibit stronger anticancer effects with improved bioavailability compared to curcumin. Objective: This study aims to investigate the toxicity effect of BHMC and curcumin on human liver cancer, HepG2 and non-cancer mouse fibroblast, 3T3. Methods: Both cell lines were purchased from ATCC and cultured in supplemented DMEM. Cell viability was determined via MTT assay and confirmed with trypan blue assay. Morphology hallmarks of apoptosis of both treated cells were analyzed using inverted microscope at 40X magnifications. Results: BHMC and curcumin were very potent towards HepG2 and normal 3T3. These data were further confirmed with trypan blue assay which showed that both compounds significantly reduced the percentage of HepG2 and 3T3 cells viability. Both treated cells also displayed all the morphology hallmarks of apoptosis upon treatment. Conclusion: BHMC has a greater cytotoxicity effect on HepG2 compared to curcumin despite its non-selective cytotoxicity effect on non-cancer 3T3. Faculty of Medicine and Health Sciences, Universiti Putra Malaysia 2019 Article PeerReviewed text en http://psasir.upm.edu.my/id/eprint/70040/1/2019070210005107_MJMHS_SP2_2019.pdf Syed Alwi, Sharifah Sakinah and Zahari, Syazwan and Haron, Aminah Suhaila and Alexander, Henna Roshini (2019) Cytotoxic effect of 2,6-bis(4-hydroxy-3-methoxybenzylidene) cyclohexanone (BHMC) and curcumin on human liver cancer cells, HepG2. Malaysian Journal of Medicine and Health Sciences, 15 (SP2). pp. 44-50. ISSN 1675-8544; ESSN: 2636-9346 https://medic.upm.edu.my/upload/dokumen/2019070210005107_MJMHS_SP2_2019.pdf
spellingShingle Syed Alwi, Sharifah Sakinah
Zahari, Syazwan
Haron, Aminah Suhaila
Alexander, Henna Roshini
Cytotoxic effect of 2,6-bis(4-hydroxy-3-methoxybenzylidene) cyclohexanone (BHMC) and curcumin on human liver cancer cells, HepG2
title Cytotoxic effect of 2,6-bis(4-hydroxy-3-methoxybenzylidene) cyclohexanone (BHMC) and curcumin on human liver cancer cells, HepG2
title_full Cytotoxic effect of 2,6-bis(4-hydroxy-3-methoxybenzylidene) cyclohexanone (BHMC) and curcumin on human liver cancer cells, HepG2
title_fullStr Cytotoxic effect of 2,6-bis(4-hydroxy-3-methoxybenzylidene) cyclohexanone (BHMC) and curcumin on human liver cancer cells, HepG2
title_full_unstemmed Cytotoxic effect of 2,6-bis(4-hydroxy-3-methoxybenzylidene) cyclohexanone (BHMC) and curcumin on human liver cancer cells, HepG2
title_short Cytotoxic effect of 2,6-bis(4-hydroxy-3-methoxybenzylidene) cyclohexanone (BHMC) and curcumin on human liver cancer cells, HepG2
title_sort cytotoxic effect of 2,6-bis(4-hydroxy-3-methoxybenzylidene) cyclohexanone (bhmc) and curcumin on human liver cancer cells, hepg2
url http://psasir.upm.edu.my/id/eprint/70040/
http://psasir.upm.edu.my/id/eprint/70040/
http://psasir.upm.edu.my/id/eprint/70040/1/2019070210005107_MJMHS_SP2_2019.pdf